Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 134

1.

Loss of striatal cannabinoid CB1 receptor function in attention-deficit / hyperactivity disorder mice with point-mutation of the dopamine transporter.

Castelli M, Federici M, Rossi S, De Chiara V, Napolitano F, Studer V, Motta C, Sacchetti L, Romano R, Musella A, Bernardi G, Siracusano A, Gu HH, Mercuri NB, Usiello A, Centonze D.

Eur J Neurosci. 2011 Nov;34(9):1369-77. doi: 10.1111/j.1460-9568.2011.07876.x.

PMID:
22034972
[PubMed - indexed for MEDLINE]
2.

The endocannabinoid system misfires in ADHD mice (commentary on Castelli et al.).

Bracci E.

Eur J Neurosci. 2011 Nov;34(9):1368. doi: 10.1111/j.1460-9568.2011.07917.x. No abstract available.

PMID:
22034971
[PubMed - indexed for MEDLINE]
3.

Role of aberrant striatal dopamine D1 receptor/cAMP/protein kinase A/DARPP32 signaling in the paradoxical calming effect of amphetamine.

Napolitano F, Bonito-Oliva A, Federici M, Carta M, Errico F, Magara S, Martella G, Nisticò R, Centonze D, Pisani A, Gu HH, Mercuri NB, Usiello A.

J Neurosci. 2010 Aug 18;30(33):11043-56. doi: 10.1523/JNEUROSCI.1682-10.2010.

PMID:
20720111
[PubMed - indexed for MEDLINE]
Free Article
4.

Voluntary exercise and sucrose consumption enhance cannabinoid CB1 receptor sensitivity in the striatum.

De Chiara V, Errico F, Musella A, Rossi S, Mataluni G, Sacchetti L, Siracusano A, Castelli M, Cavasinni F, Bernardi G, Usiello A, Centonze D.

Neuropsychopharmacology. 2010 Jan;35(2):374-87. doi: 10.1038/npp.2009.141. Epub .

PMID:
19776732
[PubMed - indexed for MEDLINE]
Free PMC Article
5.

Altered corticostriatal neurotransmission and modulation in dopamine transporter knock-down mice.

Wu N, Cepeda C, Zhuang X, Levine MS.

J Neurophysiol. 2007 Jul;98(1):423-32. Epub 2007 May 23.

PMID:
17522168
[PubMed - indexed for MEDLINE]
Free Article
6.

Interleukin-1β alters the sensitivity of cannabinoid CB1 receptors controlling glutamate transmission in the striatum.

De Chiara V, Motta C, Rossi S, Studer V, Barbieri F, Lauro D, Bernardi G, Centonze D.

Neuroscience. 2013 Oct 10;250:232-9. doi: 10.1016/j.neuroscience.2013.06.069. Epub 2013 Jul 12.

PMID:
23856068
[PubMed - indexed for MEDLINE]
7.

Brain-derived neurotrophic factor controls cannabinoid CB1 receptor function in the striatum.

De Chiara V, Angelucci F, Rossi S, Musella A, Cavasinni F, Cantarella C, Mataluni G, Sacchetti L, Napolitano F, Castelli M, Caltagirone C, Bernardi G, Maccarrone M, Usiello A, Centonze D.

J Neurosci. 2010 Jun 16;30(24):8127-37. doi: 10.1523/JNEUROSCI.1683-10.2010.

PMID:
20554863
[PubMed - indexed for MEDLINE]
Free Article
8.

Endocannabinoids activate transient receptor potential vanilloid 1 receptors to reduce hyperdopaminergia-related hyperactivity: therapeutic implications.

Tzavara ET, Li DL, Moutsimilli L, Bisogno T, Di Marzo V, Phebus LA, Nomikos GG, Giros B.

Biol Psychiatry. 2006 Mar 15;59(6):508-15. Epub 2005 Sep 30.

PMID:
16199010
[PubMed - indexed for MEDLINE]
9.

Chronic cocaine sensitizes striatal GABAergic synapses to the stimulation of cannabinoid CB1 receptors.

Centonze D, Rossi S, De Chiara V, Prosperetti C, Battista N, Bernardi G, Mercuri NB, Usiello A, Maccarrone M.

Eur J Neurosci. 2007 Mar;25(6):1631-40. Epub 2007 Apr 4.

PMID:
17408430
[PubMed - indexed for MEDLINE]
10.

Enhanced sucrose and cocaine self-administration and cue-induced drug seeking after loss of VGLUT2 in midbrain dopamine neurons in mice.

Alsiö J, Nordenankar K, Arvidsson E, Birgner C, Mahmoudi S, Halbout B, Smith C, Fortin GM, Olson L, Descarries L, Trudeau LÉ, Kullander K, Lévesque D, Wallén-Mackenzie A.

J Neurosci. 2011 Aug 31;31(35):12593-603. doi: 10.1523/JNEUROSCI.2397-11.2011.

PMID:
21880920
[PubMed - indexed for MEDLINE]
Free Article
11.

Opposite function of dopamine D1 and N-methyl-D-aspartate receptors in striatal cannabinoid-mediated signaling.

Daigle TL, Wetsel WC, Caron MG.

Eur J Neurosci. 2011 Nov;34(9):1378-89. doi: 10.1111/j.1460-9568.2011.07874.x.

PMID:
22034973
[PubMed - indexed for MEDLINE]
Free PMC Article
12.

ADHD and the dopamine transporter: are there reasons to pay attention?

Mazei-Robinson MS, Blakely RD.

Handb Exp Pharmacol. 2006;(175):373-415. Review.

PMID:
16722244
[PubMed - indexed for MEDLINE]
13.

Reduced midbrain dopamine transporter binding in male adolescents with attention-deficit/hyperactivity disorder: association between striatal dopamine markers and motor hyperactivity.

Jucaite A, Fernell E, Halldin C, Forssberg H, Farde L.

Biol Psychiatry. 2005 Feb 1;57(3):229-38.

PMID:
15691523
[PubMed - indexed for MEDLINE]
14.

Methylphenidate normalizes elevated dopamine transporter densities in an animal model of the attention-deficit/hyperactivity disorder combined type, but not to the same extent in one of the attention-deficit/hyperactivity disorder inattentive type.

Roessner V, Sagvolden T, Dasbanerjee T, Middleton FA, Faraone SV, Walaas SI, Becker A, Rothenberger A, Bock N.

Neuroscience. 2010 Jun 2;167(4):1183-91. doi: 10.1016/j.neuroscience.2010.02.073. Epub 2010 Mar 6.

PMID:
20211696
[PubMed - indexed for MEDLINE]
15.

Unbalance of CB1 receptors expressed in GABAergic and glutamatergic neurons in a transgenic mouse model of Huntington's disease.

Chiodi V, Uchigashima M, Beggiato S, Ferrante A, Armida M, Martire A, Potenza RL, Ferraro L, Tanganelli S, Watanabe M, Domenici MR, Popoli P.

Neurobiol Dis. 2012 Mar;45(3):983-91. doi: 10.1016/j.nbd.2011.12.017. Epub 2011 Dec 23.

PMID:
22207189
[PubMed - indexed for MEDLINE]
16.

Involvement of cannabinoid receptors in the regulation of neurotransmitter release in the rodent striatum: a combined immunochemical and pharmacological analysis.

Köfalvi A, Rodrigues RJ, Ledent C, Mackie K, Vizi ES, Cunha RA, Sperlágh B.

J Neurosci. 2005 Mar 16;25(11):2874-84.

PMID:
15772347
[PubMed - indexed for MEDLINE]
Free Article
17.

Adolescent atomoxetine treatment in a rodent model of ADHD: effects on cocaine self-administration and dopamine transporters in frontostriatal regions.

Somkuwar SS, Jordan CJ, Kantak KM, Dwoskin LP.

Neuropsychopharmacology. 2013 Dec;38(13):2588-97. doi: 10.1038/npp.2013.163. Epub 2013 Jul 3.

PMID:
23822950
[PubMed - indexed for MEDLINE]
18.

Abnormal sensitivity of cannabinoid CB1 receptors in the striatum of mice with experimental amyotrophic lateral sclerosis.

Rossi S, De Chiara V, Musella A, Cozzolino M, Bernardi G, Maccarrone M, Mercuri NB, Carrì MT, Centonze D.

Amyotroph Lateral Scler. 2010;11(1-2):83-90. doi: 10.3109/17482960902977954.

PMID:
19452308
[PubMed - indexed for MEDLINE]
19.

Altered CB1 receptor and endocannabinoid levels precede motor symptom onset in a transgenic mouse model of Huntington's disease.

Dowie MJ, Bradshaw HB, Howard ML, Nicholson LF, Faull RL, Hannan AJ, Glass M.

Neuroscience. 2009 Sep 29;163(1):456-65. doi: 10.1016/j.neuroscience.2009.06.014. Epub 2009 Jun 10.

PMID:
19524019
[PubMed - indexed for MEDLINE]
20.

Presynaptic control of striatal dopamine neurotransmission in adult vesicular monoamine transporter 2 (VMAT2) mutant mice.

Patel J, Mooslehner KA, Chan PM, Emson PC, Stamford JA.

J Neurochem. 2003 May;85(4):898-910.

PMID:
12716422
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk